Emvena Therapeutics Launches to Develop Preeclampsia Treatment
Emvena Therapeutics has emerged from stealth with backing from the Penn-BioNTech Innovative Therapeutics Seed Fund…
Newswire
T-Therapeutics Secures $133M for Bispecifics Development
T-Therapeutics has secured $133 million in a funding round aimed at advancing its bispecific antibody…
Phillips Medisize Expands UK Inhalation Operations with Chippenham Acquisition
Phillips Medisize is expanding its inhalation drug delivery capabilities in the UK after acquiring the…
ProMis Neurosciences Shares Drop After Acumen Drug Failure
Shares of ProMis Neurosciences, developer of an amyloid-targeting treatment for Alzheimer’s disease, experienced a significant…
Evommune Secures $1.1 Billion License Deal for EVO570
Evommune has secured exclusive rights outside Greater China to develop EVO570 from Hinova Pharmaceuticals in…
Alethio Secures $90M for Rare Blood Cancer Drug Development
Alethio has raised $90 million to develop a medicine targeting rare blood cancers, specifically myeloproliferative…
China’s Clinical Trials Face New Regulatory Challenges
In China, the landscape for clinical trials has shifted significantly due to new government regulations.…
PharmatrophiX and Circular Partner on Neurodegenerative Drugs
PharmatrophiX and Circular Genomics have partnered to advance blood-based circular RNA biomarkers in neurodegenerative drug…
CDMO Partnerships Evolve in Biopharma
David Enloe, CEO of Rose BioSolutions, argues that the traditional outsourcing model in biopharma is…
Lonza Expands U.S. CDMO Network with Merck KGaA Acquisition
Lonza plans to significantly expand its U.S. contract development and manufacturing organization (CDMO) footprint by…